Globeflex Capital L P buys $2,581,039 stake in Hill-Rom Holdings (HRC)

Hill-Rom Holdings (HRC) : Globeflex Capital L P scooped up 155 additional shares in Hill-Rom Holdings during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 10, 2016. The investment management firm now holds a total of 44,493 shares of Hill-Rom Holdings which is valued at $2,581,039.Hill-Rom Holdings makes up approximately 0.66% of Globeflex Capital L P’s portfolio.

Other Hedge Funds, Including , Segall Bryant Hamill sold out all of its stake in HRC during the most recent quarter. The investment firm sold 52,883 shares of HRC which is valued $3,067,743.Ubs Asset Management Americas Inc boosted its stake in HRC in the latest quarter, The investment management firm added 5,252 additional shares and now holds a total of 54,388 shares of Hill-Rom Holdings which is valued at $3,145,258.Royce Associates Lp reduced its stake in HRC by selling 41,000 shares or 10.01% in the most recent quarter. The Hedge Fund company now holds 368,576 shares of HRC which is valued at $21,314,750. Hill-Rom Holdings makes up approx 0.13% of Royce Associates Lp’s portfolio.Princeton Alpha Management Lp reduced its stake in HRC by selling 2,716 shares or 21.42% in the most recent quarter. The Hedge Fund company now holds 9,962 shares of HRC which is valued at $564,845. Hill-Rom Holdings makes up approx 0.10% of Princeton Alpha Management Lp’s portfolio. Quantbot Technologies Lp added HRC to its portfolio by purchasing 11,613 company shares during the most recent quarter which is valued at $630,354. Hill-Rom Holdings makes up approx 0.06% of Quantbot Technologies Lp’s portfolio.

Hill-Rom Holdings opened for trading at $57.89 and hit $58.28 on the upside on Friday, eventually ending the session at $58.23, with a gain of 0.38% or 0.22 points. The heightened volatility saw the trading volume jump to 2,08,092 shares. Company has a market cap of $3,812 M.

On the company’s financial health, Hill-Rom Holdings reported $0.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.76. The company had revenue of $655.40 million for the quarter, compared to analysts expectations of $646.61 million. The company’s revenue was up 38.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.

Investors should note that on Jul 20, 2016, Hill-Rom Holdings announced a cash dividend of $0.1700. The company’s management has announced Sep 14, 2016 as the ex-dividend date and fixed the record date on Sep 16, 2016. The payable date has been fixed on Sep 30, 2016.

Many Wall Street Analysts have commented on Hill-Rom Holdings. Hill-Rom Holdings was Upgraded by Morgan Stanley to ” Overweight” on Jun 16, 2016.

Hill-Rom Holdings Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility Wound Care and Prevention Clinical Workflow Surgical Safety and Efficiency and Respiratory Health. The Company operates in three segments: North America Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services as well as its clinical workflow solutions in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.

Leave a Reply

Hill-Rom Holdings - Is it time to Sell?

Top Brokerage Firms are advising their investors on Hill-Rom Holdings. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.